MARSHALL HOSPITAL — History
CCN 050254 | 3-year financial timeline | COVID resilience: 33/100
🛡️ Public data only — no PHI permitted on this instance.
$286M
Latest Revenue (FY2022)
-0.8%
Revenue CAGR (3yr)
-5.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $290M | $289M | $286M | -0.9% | -0.8% |
| Operating Expenses | $280M | $287M | $303M | +5.6% | +3.9% |
| Operating Margin | 3.5% | 0.6% | -5.9% | -1080.8% | +0.0% |
| Net Income | $10M | $2M | $-17M | -1071.5% | +0.0% |
| Licensed Beds | 111 | 111 | 111 | +0.0% | +0.0% |
| Total Patient Days | 19,323 | 19,526 | 19,058 | -2.4% | -0.7% |
| Medicare Day % | 46% | 41% | 42% | +2.2% | -4.3% |
| Medicaid Day % | 6% | 6% | 6% | +9.3% | +2.5% |
COVID Impact & Recovery
Resilience Score: 33/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -1.5% ($290M → $286M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▶ Stable
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-0.8%
This Hospital
+7.6%
State Avg
Latest Margin
-5.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $284M | -10.7% |
| FY2024 (proj) | $282M | -15.4% |
| FY2025 (proj) | $279M | -20.1% |